Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2025-12-24 @ 1:13 PM
NCT ID:
NCT02991495
Eligibility Criteria:
Inclusion Criteria:
* Adults population: 18 to 60 years of age
* Children population: 9 to 59 months of age
* For HIV positive population: HIV positive on serological testing
* If HIV infection, CD4 T-cell counts ≥200 cells/mm³ for adults or CD4 percentage \>25% for children
* Providing informed consent to participate in the study
Exclusion Criteria:
* Contraindications to yellow fever vaccination:
* History of yellow fever vaccination
* Previous yellow fever infection
* Requiring yellow fever vaccination for travelling purposes
* Pregnancy (as determined by a urine test on the proposed day of vaccination) and lactating women
* Refusal to participate in the study
* Planning to move out of the study area before the end of the study follow-up
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
9 Months
Maximum Age:
60 Years
Study:
NCT02991495
Study Brief:
Protocol Section:
NCT02991495